You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

F.I.T.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CAR-T Trial in Hangzhou (GC012F injection)

Recruiting
  • CAR-T
  • GC012F injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
May 10, 2023

Multiple Myeloma Trial in Shanghai (GC012F injection)

Recruiting
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Jul 23, 2022

Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)

Active, not recruiting
  • Breast Cancer Stage IV
  • Trastuzumab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
Jul 26, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Long-Term Development of Muscular Dystrophy Outcome Assessments

Not yet recruiting
  • LGMD1A
  • +33 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Aug 3, 2023

    Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • +2 more
      • Ancona, Italy
      • +19 more
      Nov 2, 2023

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

      Recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +20 more
      • Chimeric Antigen Receptor T-Cell Therapy
      • +4 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 11, 2022

      Myeloma-Multiple, Myeloma, Plasma-Cell Trial run by the NCI (Cyclophosphamide, Fludarabine, Rimiducid)

      Completed
      Has Results
      • Myeloma-Multiple
      • Myeloma, Plasma-Cell
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 19, 2021

      Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

      Recruiting
      • Castration-Resistant Prostate Carcinoma
      • +4 more
      • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Mar 17, 2022

      Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

      Recruiting
      • Recurrent Acute Lymphoblastic Leukemia
      • +15 more
      • Anti-CD19/CD20/CD22 CAR T-Cells
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 4, 2022

      New Predictive Model for Progression of Adolescent Idiopathic

      Recruiting
      • Scoliosis
        • San Diego, California
        • +8 more
        May 4, 2022

        Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

        Completed
        Has Results
        • Anaplastic Large Cell Lymphoma, ALK-Negative
        • +9 more
        • Autologous Hematopoietic Stem Cell Transplantation
        • +8 more
        • Duarte, California
        • +7 more
        Nov 4, 2022

        Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

        Active, not recruiting
        • Adult Acute Myeloid Leukemia in Remission
        • +12 more
        • Duarte, California
          City of Hope Medical Center
        Feb 17, 2022

        Recurrent DLBCL, Refractory DLBCL Trial in Sacramento (Chimeric Antigen Receptor T-Cell Therapy, Cyclophosphamide, Fludarabine

        Recruiting
        • Recurrent Diffuse Large B-Cell Lymphoma
        • Refractory Diffuse Large B-Cell Lymphoma
        • Chimeric Antigen Receptor T-Cell Therapy
        • +3 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Mar 8, 2022

        Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy Trial in Leuven, Gent ([18F]-MFBG PET CT,

        Not yet recruiting
        • Parkinson Disease
        • +3 more
        • [18F]-MFBG PET CT
        • +3 more
        • Leuven, Vlaams-Brabant, Belgium
        • +1 more
        Oct 31, 2023

        Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

        Recruiting
        • Acute Adult T-Cell Leukemia/Lymphoma
        • +3 more
        • Atlanta, Georgia
        • +13 more
        Jan 26, 2023

        Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in United States (hLL1-DOX (IMMU-115))

        Terminated
        • Non-Hodgkin's Lymphoma
        • Chronic Lymphocytic Leukemia
        • hLL1-DOX (IMMU-115)
        • Newark, Delaware
        • +5 more
        Oct 6, 2021

        F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's

        Recruiting
        • Alzheimer Disease
        • F 18 T807
        • Saint Louis, Missouri
          Washington University School of Medicine
        Sep 23, 2022

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

        Recruiting
        • Acute Lymphoblastic Leukemia
        • +3 more
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +8 more
        • Duarte, California
          City of Hope Medical Center
        Jan 12, 2023

        Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

        Not yet recruiting
        • Relapsed/ Refractory Multiple Myeloma
        • GC012F
        • (no location specified)
        Apr 28, 2023

        Natural History Study for Charcot Marie Tooth Disease

        Recruiting
        • Charcot-Marie-Tooth Disease
        • +47 more
          • New York, New York
            Hereditary Neuropathy Foundation
          Jun 12, 2023

          Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

          Recruiting
          • Recurrent B Acute Lymphoblastic Leukemia
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Nov 2, 2022

          Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

          Recruiting
          • Previously Treated Myelodysplastic Syndrome
          • +3 more
          • Fludarabine Phosphate
          • +9 more
          • Chicago, Illinois
            University of Chicago Comprehensive Cancer Center
          Jan 7, 2022

          Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)

          Not yet recruiting
          • Advanced Non Small Cell Lung Cancer
          • (no location specified)
          Oct 24, 2023

          HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

          Not yet recruiting
          • HER2-positive Breast Cancer
          • 68Ga/131I-SGMIB-5F7
          • Shanghai, China
            Huashan Hospital
          Aug 1, 2023